Growing diabetes prevalence, with over 540 million diagnosed individuals worldwide, and the increasing adoption of continuous subcutaneous insulin infusion (CSII) therapy are fueling market demand.

The MarketWatch News Department was not involved in the creation of this content. Insulin Delivery Devices Market Surges to USD 43.11 Billion by 2033 as Smart Pumps, Automated Systems & Digital ...

The U.S. Food and Drug Administration on Monday approved the expanded use of an automated insulin pump system to include those with type 2 diabetes. It's the first such system for use by people with ...

The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., June 25, 2025 /PRNewswire/ -- The global Insulin Delivery Device Market, valued at US$32.6 billion ...

Beneficiaries of Medicare and Medicare Advantage can now obtain the MiniMed 780G system combined with the Instinct sensor.

Embecta Corp (NASDAQ:EMBC), a manufacturer of disposable insulin pen needles and syringes, is considering a potential sale following a significant drop in its share price since being spun off from ...

WASHINGTON -- The U.S. government has cleared the way for the first medical device that enables automated insulin dosing for people with type 2 diabetes. The plastic pod, called the Omnipod 5 ...

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to address a ...